Aurobindo Pharma standalone net profit rises 101.33% in the September 2020 quarter

Sales rise 40.71% to Rs 4425.43 crore

Net profit of Aurobindo Pharma rose 101.33% to Rs 801.54 crore in the quarter ended September 2020 as against Rs 398.13 crore during the previous quarter ended September 2019. Sales rose 40.71% to Rs 4425.43 crore in the quarter ended September 2020 as against Rs 3145.12 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales4425.433145.12 41 OPM %27.2820.07 -PBDT1249.34639.99 95 PBT1129.20522.06 116 NP801.54398.13 101

Powered by Capital Market - Live News